dr. ilson on remaining challenges with immunotherapy in gastric cancer
Published 4 years ago • 117 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:41
dr. ilson on investigative tki combinations in gastric cancer
-
1:22
dr. ilson on chemotherapy in advanced gastric cancer
-
1:04
dr. ilson on the utility of zolbetuximab in claudin-positive gastric cancers
-
1:43
dr. ilson discusses the optimal adjuvant therapy for resectable gastric cancer
-
1:07
dr. smaglo on the future of immunotherapy in gastric cancer
-
0:44
dr. yoon on immunotherapy in gastric cancer
-
5:25
gastric/gej cancer: immunotherapeutic strategies
-
5:40
patient selection for immunotherapy in gastric cancer
-
1:33
dr. fuchs discusses immunotherapy in gastric cancer
-
2:24
the remaining challenges surrounding the use of immunotherapy to treat patients with rectal cancer
-
2:13
david h ilson, md, on the javelin 100 study and the need for quick responses and immunotherapy in ge
-
1:53
david ilson, md, phd, compares pembrolizumab & chemotherapy in advanced esophageal cancer
-
10:16
ongoing research in gastric cancer; antiangiogenic therapy upfront and immunotherapy
-
1:08
dr. ku on role of durvalumab in gastric cancer
-
2:07
dr. janjigian on immunotherapy combinations in gastric cancer
-
1:17
dr. arkenau on the potential of immunotherapy in gastric cancer
-
7:00
interpretation of data on immunotherapy use in gastric cancer
-
2:12
clinical trials investigating immunotherapy for gastric cancer
-
1:28
dr. shah on improving the benefit of immunotherapy in gastric/gej cancer